Akums Drugs Financials
| AKUMS Stock | 605.10 2.20 0.36% |
Operating Margin 0.0884 | PE Ratio 10.4 K | Profit Margin 0.0578 |
Akums |
Understanding current and past Akums Drugs Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Akums Drugs' financial statements are interrelated, with each one affecting the others. For example, an increase in Akums Drugs' assets may result in an increase in income on the income statement.
Akums Drugs Stock Summary
Akums Drugs competes with Hindustan Foods, Sportking India, Varun Beverages, Univa Foods, and Dodla Dairy. Akums Drugs is entity of India. It is traded as Stock on NSE exchange.Specialization | Healthcare, Drug Manufacturers - Specialty & Generic |
| Instrument | India Stock View All |
| Exchange | National Stock Exchange of India |
| Business Address | Plot no 131 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.akums.in |
| Phone | 91 11 6904 1000 |
Akums Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Akums Drugs's current stock value. Our valuation model uses many indicators to compare Akums Drugs value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Akums Drugs competition to find correlations between indicators driving Akums Drugs's intrinsic value. More Info.Akums Drugs and is number one stock in profit margin category among its peers. It also is number one stock in operating margin category among its peers reporting about 1.53 of Operating Margin per Profit Margin. Comparative valuation analysis is a catch-all model that can be used if you cannot value Akums Drugs by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Akums Drugs' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Akums Drugs Systematic Risk
Akums Drugs' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Akums Drugs volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Akums Drugs correlated with the market. If Beta is less than 0 Akums Drugs generally moves in the opposite direction as compared to the market. If Akums Drugs Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Akums Drugs is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Akums Drugs is generally in the same direction as the market. If Beta > 1 Akums Drugs moves generally in the same direction as, but more than the movement of the benchmark.
Akums Drugs Thematic Clasifications
Akums Drugs and is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Akums Drugs December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Akums Drugs help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Akums Drugs and. We use our internally-developed statistical techniques to arrive at the intrinsic value of Akums Drugs and based on widely used predictive technical indicators. In general, we focus on analyzing Akums Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Akums Drugs's daily price indicators and compare them against related drivers.
| Information Ratio | (0.20) | |||
| Maximum Drawdown | 15.0 | |||
| Value At Risk | (5.00) | |||
| Potential Upside | 5.0 |
Other Information on Investing in Akums Stock
Akums Drugs financial ratios help investors to determine whether Akums Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Akums with respect to the benefits of owning Akums Drugs security.